Plaque Prolapse in Carotid Artery Stenting: Mechanisms, Imaging and Device-Based Prevention
Luca Galassi1, Leonardo Pasquetti2, Federica Facchinetti3
1Postgraduate School of Vascular and Endovascular Surgery, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
Insights
Preventing plaque prolapse during carotid artery stenting (CAS) is crucial for reducing stroke risk. Dual-layer micromesh stents (DLMS) combined with embolic protection offer an advanced solution, significantly lowering periprocedural embolization and improving patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Interventional Neurology
- Medical Device Technology
Background:
- Carotid artery stenting (CAS) is a key treatment for high-risk surgical patients with carotid disease.
- Periprocedural cerebral embolization is a significant concern, with plaque prolapse identified as a direct cause of embolic events.
- Understanding and preventing plaque prolapse is essential for improving neurological outcomes after CAS.
Purpose of the Study:
- To provide a practice-oriented framework for preventing plaque prolapse during CAS.
- To review determinants of prolapse risk, including plaque morphology, procedural factors, and device selection.
- To highlight dual-layer micromesh stent (DLMS) technology as a potential solution.
Main Methods:
- Narrative review of prospective registries, comparative cohort studies, and intravascular imaging analyses (OCT, IVUS).
- Analysis of plaque morphology, procedural variables, and device characteristics influencing prolapse risk.
- Evaluation of clinical data on DLMS technology and its association with stroke rates and prolapse reduction.
Main Results:
- Pooled data show a 30-day stroke rate of approximately 1.4% with DLMS and embolic protection.
- Optical coherence tomography (OCT) studies demonstrate reduced prolapse with DLMS compared to single-layer stents.
- Integrated strategies involving lesion characterization, technique optimization, and device selection are key to prevention.
Conclusions:
- Prevention of plaque prolapse requires a multifaceted approach combining imaging, technique, and device selection.
- DLMS technology represents an advanced device-based strategy for minimizing prolapse during CAS.
- Further research with standardized imaging and robust clinical endpoints is needed to refine prevention strategies.
Abstract:
Carotid artery stenting (CAS) is an established revascularization option for patients with carotid disease at high surgical risk. Periprocedural cerebral embolization remains a clinical concern, and plaque prolapse, the extrusion of atherosclerotic material through the stent struts into the lumen, has emerged as an actionable mechanism directly linked to embolic events and adverse neurological outcomes. This narrative review provides a structured, practice-oriented framework addressing one specific question: how can plaque prolapse be prevented during CAS? Drawing on prospective registries, comparative cohort studies and intravascular imaging analyses based on optical coherence tomography (OCT) and intravascular ultrasound (IVUS), we discuss the main determinants of prolapse risk, plaque morphology, procedural variables and device selection, converging on dual-layer micromesh stent (DLMS) technology as the most advanced device-based solution available. Pooled clinical data indicate a 30-day stroke rate of approximately 1.4% when DLMSs are used in combination with embolic protection, and OCT studies confirm reduced prolapse compared with single-layer stents. Prevention requires an integrated strategy combining lesion-specific characterisation, optimised technique and tailored device selection, while standardised imaging definitions and adequately powered randomised trials with hard clinical endpoints remain research priorities.
Related Concept Videos
Atherosclerosis I: Introduction
Ischemic Stroke l: Introduction
Peripheral Artery Disease I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Transient Ischemic Attack l: Introduction
Coronary Artery Disease II: Pathophysiology

